News
Virtual. About Innate Pharma. Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunothera ...
Astrazeneca (AZN) closed the most recent trading day at $73.55, moving -1.17% from the previous trading session. The stock's ...
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
Demand is rising for AI-powered robots that can clean offices or roll around moving items from one part of a building to ...
Explore more
This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...
AstraZeneca is making a bold move. The drug giant just teamed up with CSPC in a deal worth up to $5.3 billion. The goal? To ...
AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...
The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by ...
Find insight on Regis Healthcare, CSPC Pharmaceutical and more in the latest Market Talks covering the health care sector.
AstraZeneca has signed an AI-led research agreement with China’s CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results